Table 1 Patient baseline characteristics
Variable | n = 83 | |
|---|---|---|
Age (years) | 74.0 | (65.5–78.5) |
Sex (male) (%) | 51.0 | (61.4) |
Cancer (%) | 40.0 | (48.2) |
Coronary artery disease (%) | 4.0 | (4.8) |
Diabetes mellitus (%) | 10.0 | (12.0) |
Hypertension (%) | 21.0 | (25.3) |
Albumin (g/dL) | 2.3 | (1.8–3.0) |
CRP (mg/dL) | 10.4 | (3.7–17.5) |
WBC (× 109 l−1) | 10.9 | (5.4–15.4) |
Neutrophil count (× 109 l−1) | 8.7 | (3.56–13.29) |
Lymphocyte count (× 109 l−1) | 0.5 | (0.299–0.927) |
Platelet count (× 104 mm−3) | 17.8 | (11.5–26.5) |
Fibrinogen (mg/dL) | 609.0 | (378–711) |
Survival (dead) (%) | 26.0 | (31.3) |
AKI (%) | 38.0 | (45.8) |
ARDS (%) | 13.0 | (15.7) |
Shock (%) | 48.0 | (57.8) |
DIC (%) | 30.0 | (36.1) |
Presepsin on Day 1 (pg/mL) | 1051.5 | (569–1819.3) |
Presepsin on Day 2 (ng/mL) | 1016.5 | (538–2156) |
Presepsin on Day 3 (ng/mL) | 802.0 | (480.5–1825) |
Presepsin on Day 5 (ng/mL) | 1043.0 | (480–1616) |
ΔPresepsin Day 2—Day 1 (pg/mL) | − 21.50 | (-246.5–274.75) |
ΔPresepsin Day 3—Day 1 (pg/mL) | − 38.50 | (-748.5–304) |
ΔPresepsin Day 5—Day 1 (pg/mL) | − 59.50 | (-745.75–635.5) |
GPS | 1.0 | (1–2) |
NLR | 12.6 | (4.53–26.35) |
PLR | 321.9 | (195.63–543.69) |
PI | 1.0 | (1–2) |
PNI | 26.6 | (21.26–33.72) |
SOFA | 8.0 | (5–11) |
qSOFA | 2.0 | (1–3) |